Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares is at $139.2 million.
  • Galera Therapeutics (NASDAQ:GRTX) stock moved upwards by 21.48% to $3.28. The company's market cap stands at $86.7 million.
  • Biofrontera (NASDAQ:BFRI) shares moved upwards by 16.72% to $6.42. The company's market cap stands at $92.8 million.
  • Windtree Therapeutics (NASDAQ:WINT) shares rose 11.92% to $1.69. The market value of their outstanding shares is at $47.7 million.
  • Mesoblast (NASDAQ:MESO) stock increased by 8.15% to $4.51. The company's market cap stands at $583.9 million.
  • Evofem Biosciences (NASDAQ:EVFM) shares moved upwards by 7.17% to $0.43. The market value of their outstanding shares is at $70.9 million.
  •  

Losers

  • Pulmatrix (NASDAQ:PULM) stock declined by 15.38% to $0.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $33.7 million.
  • Idera Pharmaceuticals (NASDAQ:IDRA) stock fell 14.95% to $0.74. The market value of their outstanding shares is at $39.0 million.
  • I-MAB (NASDAQ:IMAB) shares decreased by 8.41% to $45.25. The market value of their outstanding shares is at $3.5 billion.
  • Legend Biotech (NASDAQ:LEGN) stock declined by 7.28% to $45.01. The company's market cap stands at $6.5 billion.
  • Applied DNA Sciences (NASDAQ:APDN) shares fell 7.27% to $4.85. The market value of their outstanding shares is at $36.3 million. As per the news, the Q4 earnings report came out 4 days ago.
  • First Wave BioPharma (NASDAQ:FWBI) shares declined by 6.18% to $1.52. The company's market cap stands at $22.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.